Quality Assessment of an Antimicrobial Resistance Surveillance System in a Province of Nepal
Antimicrobial resistance (AMR) is a global problem, and Nepal is no exception. Countries are expected to report annually to the World Health Organization on their AMR surveillance progress through a Global Antimicrobial Resistance Surveillance System, in which Nepal enrolled in 2017. We assessed the quality of AMR surveillance data during 2019–2020 at nine surveillance sites in Province 3 of Nepal for completeness, consistency, and timeliness and examined barriers for non-reporting sites. Here, we present the results of this cross-sectional descriptive study of secondary AMR data from five reporting sites and barriers identified through a structured questionnaire completed by representatives at the five reporting and four non-reporting sites. Among the 1584 records from the reporting sites assessed for consistency and completeness, 77–92% were consistent and 88–100% were complete, with inter-site variation. Data from two sites were received by the 15th day of the following month, whereas receipt was delayed by a mean of 175 days at three other sites. All four non-reporting sites lacked dedicated data personnel, and two lacked computers. The AMR surveillance data collection process needs improvement in completeness, consistency, and timeliness. Non-reporting sites need support to meet the specific requirements for data compilation and sharing..
Media Type: |
Electronic Article |
---|
Year of Publication: |
2021 |
---|---|
Publication: |
2021 |
Contained In: |
To Main Record - volume:6 |
---|---|
Contained In: |
Tropical Medicine and Infectious Disease - 6(2021), 2, p 60 |
Language: |
English |
---|
Contributors: |
Jyoti Acharya [Author] |
---|
Links: |
doi.org [kostenfrei] |
---|
Keywords: |
Global Antimicrobial Resistance Surveillance System (GLASS) |
---|
doi: |
10.3390/tropicalmed6020060 |
---|
funding: |
|
---|---|
Supporting institution / Project title: |
|
PPN (Catalogue-ID): |
DOAJ08672018X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ08672018X | ||
003 | DE-627 | ||
005 | 20240412183309.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230311s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/tropicalmed6020060 |2 doi | |
035 | |a (DE-627)DOAJ08672018X | ||
035 | |a (DE-599)DOAJa39d19094bf74038a8d1f9c3f07811d1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Jyoti Acharya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Quality Assessment of an Antimicrobial Resistance Surveillance System in a Province of Nepal |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Antimicrobial resistance (AMR) is a global problem, and Nepal is no exception. Countries are expected to report annually to the World Health Organization on their AMR surveillance progress through a Global Antimicrobial Resistance Surveillance System, in which Nepal enrolled in 2017. We assessed the quality of AMR surveillance data during 2019–2020 at nine surveillance sites in Province 3 of Nepal for completeness, consistency, and timeliness and examined barriers for non-reporting sites. Here, we present the results of this cross-sectional descriptive study of secondary AMR data from five reporting sites and barriers identified through a structured questionnaire completed by representatives at the five reporting and four non-reporting sites. Among the 1584 records from the reporting sites assessed for consistency and completeness, 77–92% were consistent and 88–100% were complete, with inter-site variation. Data from two sites were received by the 15th day of the following month, whereas receipt was delayed by a mean of 175 days at three other sites. All four non-reporting sites lacked dedicated data personnel, and two lacked computers. The AMR surveillance data collection process needs improvement in completeness, consistency, and timeliness. Non-reporting sites need support to meet the specific requirements for data compilation and sharing. | ||
650 | 4 | |a Global Antimicrobial Resistance Surveillance System (GLASS) | |
650 | 4 | |a reference laboratory | |
650 | 4 | |a NPHL | |
650 | 4 | |a SORT IT | |
650 | 4 | |a operational research | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Maria Zolfo |e verfasserin |4 aut | |
700 | 0 | |a Wendemagegn Enbiale |e verfasserin |4 aut | |
700 | 0 | |a Khine Wut Yee Kyaw |e verfasserin |4 aut | |
700 | 0 | |a Meika Bhattachan |e verfasserin |4 aut | |
700 | 0 | |a Nisha Rijal |e verfasserin |4 aut | |
700 | 0 | |a Anjana Shrestha |e verfasserin |4 aut | |
700 | 0 | |a Basudha Shrestha |e verfasserin |4 aut | |
700 | 0 | |a Surendra Kumar Madhup |e verfasserin |4 aut | |
700 | 0 | |a Bijendra Raj Raghubanshi |e verfasserin |4 aut | |
700 | 0 | |a Hari Prasad Kattel |e verfasserin |4 aut | |
700 | 0 | |a Piyush Rajbhandari |e verfasserin |4 aut | |
700 | 0 | |a Parmananda Bhandari |e verfasserin |4 aut | |
700 | 0 | |a Subhash Thakur |e verfasserin |4 aut | |
700 | 0 | |a Saroj Sharma |e verfasserin |4 aut | |
700 | 0 | |a Dipendra Raman Singh |e verfasserin |4 aut | |
700 | 0 | |a Runa Jha |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Tropical Medicine and Infectious Disease |d MDPI AG, 2017 |g 6(2021), 2, p 60 |w (DE-627)102556488X |x 24146366 |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2021 |g number:2, p 60 |
856 | 4 | 0 | |u https://doi.org/10.3390/tropicalmed6020060 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/a39d19094bf74038a8d1f9c3f07811d1 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2414-6366/6/2/60 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2414-6366 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 6 |j 2021 |e 2, p 60 |